$0.93
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
COCP: Presentation Highlights CDI-988
Overview
52-week range
$0.86
$2.67
4% of range
Avg surprise (last 3)
+25.3%
Avg reaction (last 2)
-3.1%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.17 | $-0.15 | -13.3% | +26.1% | -4.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.19 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.20 | $-0.30 | +33.3% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.23 | $-0.52 | +55.8% | — | -1.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.49 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.53 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.39 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.41 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.41 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | -$0.17 | -$0.20 | +15.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $225,000 | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-2M | — | $-2M | $-2M | $-2M | — | $-5M | $-5M |
| Net income | $-2M | — | $-2M | $-2M | $-2M | — | $-5M | $-5M |
| EPS (diluted) | $-0.17 | — | $-0.19 | $-0.20 | $-0.23 | — | $-0.49 | $-0.53 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | $18M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $6M | $8M | $9M | $7M | $9M | $12M | $14M | $20M |
| Total assets | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M |
| Total equity | $4M | $6M | $8M | $5M | $7M | $10M | $13M | $17M |
Implied volatility — last 90 days
No IV snapshots yet for COCP.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.